01 November 1999
Effect of glutamic acid, aspartic acid, glycine and gamma amino butyric acid on the growth of human leukemia and melanoma cells in vitro
Harrison Boldizasr, Bela Szende, Ferenc TimarMed Sci Monit 1999; 5(6): BR1059-1064 :: ID: 502974
Abstract
K 562 human leukemia cells and HT 168 melanoma cells were cultured for 72 hours in Minimal Essential Medium (MEM) with or without asparagine. (AspNH2) and supplemented with 2.6 mmol/l glycine (Gly), 1.9 mmol/l gamma amino butyric acid (GABA), 1.5 mmol/l aspartic acid (Asp) or 6.8 mmol/l glutamic acid (Glu). Gly significantly inhibited the proliferation of both types of tumor cells both in the presence and the absence of AspNH2. This inhibitory effect developed gradually, usually by the 48th hour of incubation. Some of the Gly-treated cells showed signs indicative of apoptosis. In AspNH2-free MEM both the control and the experimental cell groups (supplemented with Gly, GABA, Asp or Glu) showed much slower proliferation than in MEM containing AspNH2. The values obtained in GABA-supplemented MEM in 72 hour experiment did not differ significantly from the control. Glu and Asp induced a significant rise in the growth of leukemia cells by the 3rd day of incubation. The growth of melanoma cells in Glu- or Asp-containing MEM did not significantly
differ from the control but significantly exceeded the value obtained in MEM supplemented with Gly. It is supposed that Cl-transport into tumor cells decreases and Na+ transport increases as a result of changes in the extracellular/intracellular ratio of excitatory/inhibitory amino acids. This results in depolarization which maintains cell division. The results suggest that some non-essential, transmitter amino acids exert either inhibitory or stimulating effect on tumor cell proliferation. This finding may open up new possibilities in preventing tumor growth.
Keywords: leukaemia and melanoma cells, transmitter amino acids, tumor cell proliferation
Editorial
04 June 2022 : Editorial
Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?DOI: 10.12659/MSM.937371
Med Sci Monit 2022; 28:e937371
In Press
27 Jun 2022 : Clinical Research
Automatic Identification of Depression Using Facial Images with Deep Convolutional Neural NetworkMed Sci Monit In Press; DOI: 10.12659/MSM.936409
23 Jun 2022 : Clinical Research
A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, w...Med Sci Monit In Press; DOI: 10.12659/MSM.936706
22 Jun 2022 : Clinical Research
A Single-Center Study Comparing the Effects of Thoracic Spine Manipulation vs Mobility Exercises in 26 Offi...Med Sci Monit In Press; DOI: 10.12659/MSM.937316
21 Jun 2022 : Clinical Research
Optimal Timing and Outcomes of Minimally Invasive Approach in Acute Biliary PancreatitisMed Sci Monit In Press; DOI: 10.12659/MSM.937016
Most Viewed Current Articles
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review article
Long-Term Respiratory and Neurological Sequelae of COVID-19DOI :10.12659/MSM.928996
Med Sci Monit 2020; 26:e928996
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952